ISSN:

Journal Home

Pilot and Feasibility Studies Q2 Unclaimed

BioMed Central Ltd United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Pilot and Feasibility Studies is a journal indexed in SJR in Medicine (miscellaneous) with an H index of 29. It is an CC BY + CC0 Journal with a Single blind Peer Review review system, and It has a price of 1790 €. The scope of the journal is focused on clinical trials, medical evidence, biomedicine. It has an SJR impact factor of 0,568 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,568.

Type: Journal

Type of Copyright: CC BY + CC0

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Medicine (miscellaneous) (Q2)

Price

1790 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,568

SJR Impact factor

29

H Index

192

Total Docs (Last Year)

662

Total Docs (3 years)

9823

Total Refs

1099

Total Cites (3 years)

658

Citable Docs (3 years)

1.52

Cites/Doc (2 years)

51.16

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Clinical Rheumatology Q2
Pharmacological Reports Q2
Journal of Human Nutrition and Dietetics Q2
Diseases of the Colon and Rectum Q2
Oncology Reports Q2

Compare this journals

Aims and Scope

Clinical trials Medical evidence Biomedicine